Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines.

Maestroni, Georges

Maestroni, Georges.

Maestroni G; Center of Research in Medical Pharmacology, University of Insubria, Varese, Italy. georges.maestroni@tim.it.

J Neuroimmune Pharmacol ; 15(4): 572-573, 2020 12.

Article in English | MEDLINE | ID: covidwho-1064036

Subject(s)

Adjuvants, Immunologic/administration & dosage; COVID-19 Vaccines/administration & dosage; COVID-19/prevention & control; Melatonin/administration & dosage; SARS-CoV-2/drug effects; Animals; Antioxidants/administration & dosage; COVID-19/immunology; Humans; Immunity/drug effects; Immunity/immunology; SARS-CoV-2/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Adjuvants, Immunologic / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Melatonin Topics: Vaccines Limits: Animals / Humans Language: English Journal: J Neuroimmune Pharmacol Journal subject: Allergy and Immunology / Pharmacology / Neurology Year: 2020 Document Type: Article Affiliation country: S11481-020-09956-1

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google